Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: Systematic review with meta-analysis and trial sequential analysis

BMJ (Online)

Volumn 346, Issue 7900, 2013, Pages

  Haase, Nicolai ^a   Perner, Anders ^a   Hennings, Louise Inkeri ^a   Siegemund, Martin ^b   Lauridsen, Bo ^a   Wetterslev, Mik ^a   Wetterslev, Jørn ^a  

^a Rigshospitalet   (Denmark)

^b Hospital Baden   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

HETASTARCH; HUMAN ALBUMIN;

ARTICLE; BLEEDING; BLOOD TRANSFUSION; CRYSTALLOID; DRUG HYPERSENSITIVITY; FLUID THERAPY; HUMAN; KIDNEY INJURY; LENGTH OF STAY; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RISK ASSESSMENT; SEPSIS; SEQUENTIAL ANALYSIS; SYSTEMATIC REVIEW;

FLUID THERAPY; HETASTARCH; HUMANS; ISOTONIC SOLUTIONS; SEPSIS; SERUM ALBUMIN;

EID: 84875444043     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.f839     Document Type: Article

References (67)

1. Finfer S, Liu B, Taylor C, Bellomo R, Billot L, Cook D, et al. Resuscitation fluid use in critically ill adults: an international cross-sectional study in 391 intensive care units. Crit Care 2010;14:R185.
2. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008;358:125-39.
3. Schortgen F, Lacherade JC, Bruneel F, Cattaneo I, Hemery F, Lemaire F, et al. Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study. Lancet 2001;357:911-6. (Pubitemid 32247279)
4. Hartog CS, Kohl M, Reinhart K. A systematic review of third-generation hydroxyethyl starch (HES 130/0.4) in resuscitation: safety not adequately addressed. Anesth Analg 2011;112:635-45.
5. Dart AB, Mutter TC, Ruth CA, Taback SP. Hydroxyethyl starch (HES) versus other fluid therapies: effects on kidney function. Cochrane Database Syst Rev 2010;(1):CD007594.
6. Perel P, Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2011;(6):CD000567.
7. Bunn F, Trivedi D, Ashraf S. Colloid solutions for fluid resuscitation. Cochrane Database Syst Rev 2012;(6):CD001319.
8. Gattas DJ, Dan A, Myburgh J, Billot L, Lo S, Finfer S. Fluid resuscitation with 6% hydroxyethyl starch (130/0.4) in acutely ill patients: an updated systematic review and meta-analysis. Anesth Analg 2012;114:159-69.
9. Perner A, Haase N, Guttormsen AB, Tenhunen J, Klemenzson G, Åneman A, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012;367:124-34.
10. Myburgh JA, Finfer S, Bellomo R, Billot L, Cass A, Gattas D, et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012;367:1901-11.
11. Guidet B, Martinet O, Boulain T, Philippart F, Poussel JF, Maizel J, et al. Assessment of hemodynamic efficacy and safety of 6% hydroxyethylstarch 130/0.4 vs. 0.9% NaCl fluid replacement in patients with severe sepsis: The CRYSTMAS study. Crit Care 2012;16:R94.
12. Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions, version 5.1.0 [updated March 2011]. The Cochrane Collaboration 2011. Available from www. cochrane-handbook.org; 2012.
13. Sweeting MJ, Sutton AJ, Lambert PC. What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004;23:1351-75. (Pubitemid 38594143)
14. Wetterslev J, Thorlund K, Brok J, Gluud C. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. J Clin Epidemiol 2008;61:64-75. (Pubitemid 350245732)
15. Higgins JP, Whitehead A, Simmonds M. Sequential methods for random-effects meta-analysis. Stat Med 2011;30:903-21.
16. Thorlund K, Imberger G, Walsh M, Chu R, Gluud C, Wetterslev J, et al. The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis - a simulation study. PLoS One 2011;6:e25491.
17. Brok J, Thorlund K, Gluud C, Wetterslev J. Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses. J Clin Epidemiol 2008;61:763-9.
18. Wetterslev J, Thorlund K, Brok J, Gluud C. Estimating required information size by quantifying diversity in random-effects model meta-analyses. BMC Med Res Methodol 2009;9:86.
19. Ando Y, Terao Y, Fukusaki M, Yamashita K, Takada M, Tanabe T, et al. Influence of low-molecular-weight hydroxyethyl starch on microvascular permeability in patients undergoing abdominal surgery: comparison with crystalloid. J Anesth 2008;22:391-6.
20. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN, Le TT, et al. Comparison of three fluid solutions for resuscitation in dengue shock syndrome. N Engl J Med 2005;353:877-89. (Pubitemid 41247927)
21. Asfar P, Kerkeni N, Labadie F, Gouëllo JP, Brenet O, Alquier P. Assessment of hemodynamic and gastric mucosal acidosis with modified fluid versus 6% hydroxyethyl starch: a prospective, randomized study. Intens Care Med 2000;26:1282-7.
22. Boldt J, Heesen M, Welters I, Padberg W, Martin K, Hempelmann G. Does the type of volume therapy influence endothelial-related coagulation in the critically ill? Brit J Anaesth 1995;75:740-6.
23. Boldt J, Muller M, Heesen M, Neumann K, Hempelmann GG. Influence of different volume therapies and pentoxifylline infusion on circulating soluble adhesion molecules in critically ill patients. Crit Care Med 1996;24:385-91. (Pubitemid 26097829)
24. Boldt J, Mueller M, Menges T, Papsdorf M, Hempelmann G. Influence of different volume therapy regimens on regulators of the circulation in the critically ill. Brit J Anaesth 1996;77:480-7. (Pubitemid 26341035)
25. Boldt J, Müller M, Mentges D, Papsdorf M, Hempelmann G. Volume therapy in the critically ill: is there a difference? Intens Care Med 1998;24:28-36. (Pubitemid 28190786)
26. Boldt J, Suttner S, Huttner I, Kumle B, Piper S, Krumholz W. Are cost of a crystalloid-based volume replacement regimen lower than of a colloid-based volume replacement strategy? Infusionsther Transfusionsmed 2001;28:144-9. (Pubitemid 32588827)
27. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Brit J Anaesth 2002;89:722-8. (Pubitemid 35277221)
28. Boldt J, Ducke M, Kumle B, Papsdorf M, Zurmeyer EL. Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery. Intens Care Med 2004;30:416-22. (Pubitemid 38375615)
29. Boldt J, Schölhorn T, Mayer J, Piper S, Suttner S. The value of an albumin-based intravascular volume replacement strategy in elderly patients undergoing major abdominal surgery. Anest Analg 2006;103:191-9. (Pubitemid 44036058)
30. Bulanov Alu, Gorodetskii V, Shulutko EM, Vasil'ev SA, Orel EB, Malofeev VN, et al. Effect of different colloid volume-replacing solutions on a changed hemostasis system. Anesteziologiia i Reanimatologiia 2004;Mar-Apr:25-30.
31. Chen F, Wang C, Wang Y, Lin M, Ke J, Zhang Z. Effect of infusion with different volume expanders on cytokines in choleystitis patients undergoing cholecystectomy. Med J Wuhan University 2006;27:520-2. (Pubitemid 44433856)
32. Franz A, Braeunlich P, Gamsjager T, Felfernig M, Gustorff B, Kozek-Langenecker SA. The effects of hydroxyethyl starches of varying molecular weights on platelet function. Anesth Analg 2001;92:1402-7. (Pubitemid 32493149)
33. Gondos T, Marjanek Z, Ulakcsai Z, Szabo Z, Bogar L, Karolyi M, et al. Short-term effectiveness of different volume replacement therapies in postoperative hypovolaemic patients. Eur J Anaesth 2010;27:794-800.
34. Haas T, Preinreich A, Oswald E, Pajk W, Berger J, Kuehbacher G, et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 2007;62:1000-7. (Pubitemid 47399393)
35. Harten J, Crozier JE, McCreath B, Hay A, McMillan DC, McArdle CS, et al. Effect of intraoperative fluid optimisation on renal function in patients undergoing emergency abdominal surgery: a randomised controlled pilot study (ISRCTN 11799696). Int J Surg 2008;6:197-204.
36. Van der Heijden M, Verheij J, van Nieuw Amerongen GP, Groeneveld AB. Crystalloid or colloid fluid loading and pulmonary permeability, edema, and injury in septic and nonseptic critically ill patients with hypovolemia. Crit Care Med 2009;37:1275-81.
37. Jones SB, Whitten CW, Despotis GJ, Monk TG. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesth Analg 2003;96:363-8. (Pubitemid 36125747)
38. Jover JL, García JP, Martínez C, Espí A, Gregori E, Almagro J. [Hydroxyethyl starch to protect renal function in laparoscopic surgery]. Rev Esp Anestesiol Reanim 2009;56:27-30.
39. Kumle B, Boldt J, Piper S, Schmidt C, Suttner S, Salopek S. The influence of different intravascular volume replacement regimens on renal function in the elderly. Anesth Analg 1999;89:1124-30. (Pubitemid 29521926)
40. Li F, Sun H, Han XD. The effect of different fluids on early fluid resuscitation in septic shock. Zhongguo Wei Zhong Bing Ji Jin Yi Xue 2008;20:472-5.
41. Mukhtar A, Aboulfetouh F, Obayah G, Salah M, Emam M, Khater Y, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anest Analg 2009;109:924-30.
42. Pape L, Ahlenstiel T, Ehrich J. Equivalent efficacy of HES 130/0.4 and albumin infusions in children. Pediatr Nephrol 2008;23:1630.
43. Protsenko DN, Leiderman IN, Grigor'ev EV, Kokarev EA, Levit AL, Gel'fand BR. Evaluation of the effectiveness and safety of synthetic colloid solutions in the treatment of severe abdominal sepsis: a randomized comparative study. Anesteziol Reanim 2009;9-13.
44. Schramko AA, Suojaranta-Ylinen RT, Kuitunen AH, Raivio PM, Kukkonen SI, Niemi TT. Comparison of the effect of 6% hydroxyethyl starch and gelatine on cardiac and stroke volume index: a randomized, controlled trial after cardiac surgery. Perfusion-UK 2010;25:283-91.
45. Kim DH, Beez M, Kulkarni H. Comparative hemodynamic evaluation of hydroxyethyl starch (HES 130/0.4) and albumin in high-risk surgical patients. Transfus Altern Transfus Med 2005;7:79.
46. Reine PA, Kongsgaard UE, Andersen A, Thøgersen AK, Olsen H. Infusion of albumin attenuates changes in serum protein binding of drugs in surgical patients compared with volume replacement with HAES. Acta Anaesth Scand 2008;52:406-12. (Pubitemid 351207974)
47. Trof RJ, Sukul SP, Twisk JW, Girbes AR, Groeneveld AB. Greater cardiac response of colloid than saline fluid loading in septic and non-septic critically ill patients with clinical hypovolaemia. Intensive Care Med 2010;36:697-701.
48. Veneman TF, Nijhuis JO, Woittiez AJJ. Human albumin and starch administration in critically ill patients: a prospective randomized clinical trial. Wien Klin Wochenschr 2004;116:305-9. (Pubitemid 38843137)
49. Verheij J, van Lingen A, Raijmakers PGHM, Rijnsburger ER, Veerman DP, Wisselink W, et al. Effect of fluid loading with saline or colloids on pulmonary permeability, oedema and lung injury score after cardiac and major vascular surgery. Brit J Anaesth 2006;96:21-30. (Pubitemid 43124526)
50. Du XJ, Hu WM, Xia Q, Huang ZW, Chen GY, Jin XD, et al. Hydroxyethyl starch resuscitation reduces the risk of intra-abdominal hypertension in severe acute pancreatitis. Pancreas 2011;40:1220-5.
51. Basel Starch Evaluation in Sepsis (BaSES). Last verified August 2011. 2012. http://clinicaltrials.gov/ct2/show/NCT00273728.
52. Palumbo D, Servillo G, D'Amato L, Volpe ML, Capogrosso G, De Robertis E, et al. The effects of hydroxyethyl starch solution in critically ill patients. Minerva Anestesiol 2006;72:655-64. (Pubitemid 44251571)
53. Dolecek M, Svoboda P, Kantorová I, Scheer P, Sas I, Bíbrová J, et al. Therapeutic influence of 20% albumin versus 6% hydroxyethylstarch on extravascular lung water in septic patients: a randomized controlled trial. Hepato-gastroenterol 2009;56:1622-8.
54. Dubin A, Pozo MO, Casabella CA, Murias G, Moseinco MC, Kanoore Edul VS, et al. Comparison of 6% hydroxyethyl starch 130/0.4 and saline solution for resuscitation of the microcirculation during the early goal-directed therapy of septic patients. J Crit Care 2010;25:659.e1-659.e8.
55. Lv J, Zhao H-Y, Liu F, An Y-Z. The influence of lactate Ringer solution versus hydroxyethyl starch on coagulation and fibrinolytic system in patients with septic shock. Zhongguo Wei Zhong Bing Ji Jin Yi Xue 2012;24:38-41.
56. Zhu G-C, Quan Z-Y, Shao Y-S, Zhao J-G, Zhang Y-T. The study of hypertonic saline and hydroxyethyl starch treating severe sepsis. Zhongguo Wei Zhong Bing Ji Jin Yi Xue 2011;23:150-3.
57. ICH Steering Committee. International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use. ICH harmonised tripartite guideline for good clinical practice, 3rd ed. Brookwood Medical Publications;1998.
58. Bellmann R, Feistritzer C, Wiedermann CJ. Effect of molecular weight and substitution on tissue uptake of hydroxyethyl starch: a meta-analysis of clinical studies. Clin Pharmacokinet 2012;51:225-36.
59. Pillebout E, Nochy D, Hill G, Conti F, Antoine C, Calmus Y, et al. Renal histopathological lesions after orthotopic liver transplantation (OLT). Am J Transplant 2005;5:1120-9. (Pubitemid 40571263)
60. Christidis C, Mal F, Ramos J, Senejoux A, Callard P, Navarro R, et al. Worsening of hepatic dysfunction as a consequence of repeated hydroxyethylstarch infusions. J Hepatol 2001;35:726-32. (Pubitemid 34717663)
61. Schmidt-Hieber M, Loddenkemper C, Schwartz S, Arntz G, Thiel E, Notter M. Hydrops lysosomalis generalisatus - an underestimated side effect of hydroxyethyl starch therapy? Eur J Haematol 2006;77:83-5. (Pubitemid 43876211)
62. Clermont G, Acker CG, Angus DC, Sirio CA, Pinsky MR, Johnson JP. Renal failure in the ICU: comparison of the impact of acute renal failure and end-stage renal disease on ICU outcomes. Kidney Int 2002;62:986-96. (Pubitemid 35316729)
63. Bagshaw SM, Uchino S, Bellomo R, Morimatsu H, Morgera S, Schetz M, et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007;2:431-9.
64. Thomas-Rueddel DO, Vlasakov V, Reinhart K, Jaeschke R, Rueddel H, Hutagalung R, et al. Safety of gelatin for volume resuscitation - a systematic review and meta-analysis. Intensive Care Med 2012;38:1134-42.
65. Finfer S, McEvoy S, Bellomo R, McArthur C, Myburgh J, Norton R. Impact of albumin compared to saline on organ function and mortality of patients with severe sepsis. Intensive Care Med 2011;37:86-96.
66. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, and the ADQI workgroup. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004;8:R204-12.
67. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11:R31.